Home › Funds › Crosspoint Capital Strategies, LLC › MRNA
Crosspoint Capital Strategies, LLC position in MRNA
MODERNA INC · Health Care
Crosspoint Capital Strategies, LLC reported holding 20,355 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$3.9M, representing 3.77% of its reported portfolio and ranking #7 among its reported holdings. Crosspoint Capital Strategies, LLC first reported this position in Q3 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Crosspoint Capital Strategies, LLC's MRNA position evolved
Crosspoint Capital Strategies, LLC first disclosed a stake in MRNA in Q3 2026 at 20,355 shares (US$3.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 20.36K | $3.92M | New |
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 42 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Fidelity Management & Research (FMR) 58.96M sh · $11.35B · Q3 2026
- Capital World Investors 22.64M sh · $4.36B · Q3 2026
- Baillie Gifford & Co 11.44M sh · $2.20B · Q3 2026
- Theleme Partners LLP 6.66M sh · $1.28B · Q3 2026
- IMC-Chicago, LLC 3.07M sh · $590.92M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $444.49M · Q3 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- Flagship Pioneering, LLC 4.63M sh · $324.39M · Q2 2026
- a16z Perennial Management, L.P. 1.52M sh · $292.57M · Q3 2026
- Douglas Lane & Associates, LLC 1.16M sh · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M sh · $192.58M · Q3 2026
- Lingotto Investment Management LLP 749.21K sh · $144.27M · Q3 2026
More on Crosspoint Capital Strategies, LLC
FAQ
How long has Crosspoint Capital Strategies, LLC held MRNA?
Crosspoint Capital Strategies, LLC has disclosed MRNA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Crosspoint Capital Strategies, LLC's current position in MRNA?
As of Q3 2026, Crosspoint Capital Strategies, LLC holds 20.36K shares of MRNA (MODERNA INC), valued at $3.92M, representing 3.77% of its reported portfolio and ranking #7.
Has Crosspoint Capital Strategies, LLC been buying or selling MRNA?
In the latest 13F filing (Q3 2026), Crosspoint Capital Strategies, LLC newly opened its position in MRNA.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.